Enterprise Value to EBITDA Multiple ratio Analysis of Eagle Pharmaceuticals Inc - Deep Dive
Latest FY EV to EBITDA
Period Ending - Dec-22
Excellent EV to EBITDA
0.919
Period Ending - Dec-21
Very Good EV to EBITDA
7.82
Growth
-88.25 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-22
Excellent EV to EBITDA
1.38
EV to EBITDA Analysis of Eagle Pharmaceuticals Inc
Enterprise Value to EBITDA 0.919 of Eagle Pharmaceuticals Inc indicate that a company is more attractive or undervalued in the market. |
EV to EBITDA Ratio of EGRX drastically fell by -88.25 % this year. |
EV to EBITDA Ratio with value of 7.82 was highest in Year Dec-21 in last Five Years. |
EV to EBITDA Ratio with value of -0.471 was lowest in Year Dec-19 in last Five Years. |
Latest EV to EBITDA Ratio with value of 0.919 is lower than Average EV to EBITDA of 1.70 in last five years. |
Other EV to EBITDA Related Info of EGRX that may interest you.
Eagle Pharmaceuticals Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
EGRX | 4.06 | 3.85 | 5.45 % | Drug Manufacturers-Specialty & Generic |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..EV to EBITDA Related Ratios
EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
Good Value |
FY - Historical Enterprise Value to EBITDA Multiple of Eagle Pharmaceuticals Inc
Period | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
---|---|---|---|---|---|---|---|
EV to EBITDA | 0.919 | 7.82 | -0.470 | -0.471 | 0.684 | -0.0294 | 0.253 |
Change | -88.25 % | 1764.88 % | 0.206 % | -168.90 % | 2423.44 % | -111.64 % | 105.17 % |
FY Chart of Enterprise Value to EBITDA Multiple of Eagle Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)